Case–control study
Case–control study is a type of observational study in epidemiology that is often used to identify factors that may contribute to a medical condition by comparing subjects who have that condition/disease (the 'cases') with patients who do not have the condition/disease but are otherwise similar (the 'controls').
Overview
The case–control study design is often used in the study of rare diseases or as a preliminary study where little is known about the association between the risk factor and disease of interest. Compared to cohort studies, case–control studies are relatively quick and inexpensive, and they are particularly suitable for studying diseases with long latency periods.
Methodology
In a case–control study, an existing group of cases is defined at the start of the study. Then, a group of controls is selected to match the cases in terms of certain characteristics such as age, gender, or other variables. The exposure to the risk factor in each group is then retrospectively assessed.
Strengths and Weaknesses
Case–control studies have several strengths. They are efficient for rare diseases or diseases with a long latency period between exposure and disease manifestation. They are less costly and less time-consuming; they are advantageous when exposure data is expensive or hard to obtain. They are also advantageous when studying dynamic populations in which follow-up is difficult.
However, case–control studies also have inherent limitations. They are not suitable for studying rare exposures. Furthermore, the temporal sequence between exposure and outcome is not always clear. Recall bias, selection bias and observer bias are also of concern.
Examples
One of the most significant case–control studies was the Lung Health Study, which identified the link between tobacco smoking and lung cancer. Another notable case–control study was the British Doctors Study, which related tobacco smoking with various health effects including lung cancer and heart disease.
See also
This epidemiology-related article is a stub. You can help WikiMD by expanding it.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD